Amy Billett, MD

Director of Safety and Quality, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center; Associate Professor of Pediatrics, Harvard Medical School

Amy Billett is the Principal Investigator of a project through Ariadne Labs called “Making It Easier to Care for Your Central Line at Home: A Standardized Process to Reduce Ambulatory Central Line Associated Bloodstream Infections (CLABSI).” This project is developing a model to decrease infection rates in pediatric hematology/oncology patients by ensuring that patients and their families develop the confidence and skills to perform best practice central line care at home correctly, every time with decreased distress. Preliminary results demonstrate that the project is feasible and well received by families, and suggest a decrease in infection rates. The team is now seeking to apply this model to high risk medication administration in the home.